TITLE

Flecainide

PUB. DATE
December 2016
SOURCE
Reactions Weekly;12/2/2016, Vol. 1630 Issue 1, p110
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
An abstract of the article "Use of anti arrhythmic drugs (AAD) in management of patients with atrial fibrillation (AF), single center experience" by M.A. Ahmed and others is presented.
ACCESSION #
119881893

 

Related Articles

  • Fatigue in a Patient with Atrial Fibrillation. Germano, Joseph J.; Steingart, Richard M. // Cortlandt Forum;8/25/2002, Vol. 15 Issue 8, p68 

    Describes a case of fatigue in a patient with atrial fibrillation. Reason for administration of amiodarone; Multiorgan side effects of amiodarone; Characteristics and physiologic effects of amiodarone.

  • The P450 system and CV outcomes with clopidogrel. Kuritzky, Louis // Internal Medicine Alert;12/15/2010 Supplement, p183 

    The article offers information on the impact of the P450 system and clopidogrel on the reduction of cardio-vascular events (CV) among people with atrial fibrillation.

  • Risk assessment for bleeding during warfarin therapy. Kuritzky, Louis // Internal Medicine Alert;12/15/2010 Supplement, p183 

    The article offers information on the role of the HAS-BLED stratification tool in evaluating one-year risk of bleeding in patients with atrial fibrillation (AF) who were undergoing warfarin therapy.

  • Rivaroxaban Tablets (Xarelto®). Elliott, William T.; Chan, James // Internal Medicine Alert;12/15/2011, Vol. 33 Issue 23, p181 

    The article reports that an oral factor xa inhibitor named Rivaroxaban has been approved for minimizing the risk of stroke and systemic embolism in patients suffering from atrial fibrillation (AF).

  • Ours is a special community. Phoon, Colin K. L. // Cardiology in the Young;Apr2015, Vol. 25 Issue 4, p611 

    A personal narrative is presented which explores the author's experience of helping his cousin suffering from atrial fibrillation.

  • New QOF warfarin targets.  // Pulse;6/15/2011, Vol. 71 Issue 22, p8 

    The article reports that additional indicators were added to the quality and outcomes framework (QOF) by the National Institute for Health and Care Excellence that will increase the prescription of warfarin to patients with atrial fibrillation in Great Britain.

  • A Triumph Over Distance. Frank, Walter E. // Cortlandt Forum;01/25/2001, Vol. 14 Issue 1, p63 

    Presents the case of a minister who had a history of palpitations and was diagnosed with paroxysmal atrial fibrillation. Medications that the minister brought to Siberia while doing missionary work; Minister's return to the United States when he began having palpitations that would not stop;...

  • Dabigatran useful for high-risk AF patients.  // Pulse;11/24/2010, Vol. 70 Issue 36, p9 

    The article focuses on an international study wherein dabigatran are found to be an efficient alternative anticoagulant for patients with atrial fibrillation.

  • A Clinical Profile of Idiopathic Atrial Fibrillation. Peter, Robert H.; Gracey, Jack G.; Beach, Thomas B. // Annals of Internal Medicine;Jun68, Vol. 68 Issue 6, p1288 

    Presents information on a study which observed patients with idiopathic atrial fibrillation. Methodology; Results; Discussion.

  • The current status of amiodarone adverse event monitoring. Dixon, Dave L.; Kim, Janice // Cardiology Today;Dec2013, Vol. 16 Issue 12, p32 

    The article reports on the status of monitoring the adverse effects of amiodarone among atrial fibrillation (AF) patients with hypertension, heart failure (HF) or left ventricular hypertrophy and recommends careful follow-up and monitoring of the liver and thyroid and drug-drug interaction.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics